Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.53−0.09 (-1.95%)
Close on Nov 13, 2026Market cap $716.08KP/E –Yield –
Clearmind Medicine total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Clearmind Medicine
Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?